Sagimet Biosciences receives FDA nod to begin testing its therapy for acne
Reuters
03-11
March 11 (Reuters) - Sagimet Biosciences Inc :: *SAGIMET BIOSCIENCES ANNOUNCES CLEARANCE OF IND FOR FASN INHIBITOR TVB-3567, TO BE DEVELOPED FOR THE TREATMENT OF ACNE *SAGIMET BIOSCIENCES INC - FIRST-IN-HUMAN PHASE 1 TRIAL OF TVB-3567 PLANNED IN 2025